Teva

Latest stories

7h
Business Wire
Sosei Subsidiary Heptares Announces Positive Results from Phase 1b Clinical Trial with HTL9936, a First-Class Selective Muscarinic M1 Receptor Agonist for Improving Cognition in Dementia and SchizophreniaTOKYO--(BUSINESS WIRE)--Sosei Group Corporation (“Sosei”; TOKYO Mothers Index:
Sosei Subsidiary Heptares Announces Positive Results from Phase 1b Clinical Trial with HTL9936, a First-Class Selective Muscarinic M1 Receptor Agonist for Improving Cognition in Dementia and Schizophrenia
Business Wire / Posted 7 hours ago
TOKYO--(BUSINESS WIRE)--Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today reports that Heptares Therapeutics (“Heptares”), the wholly-owned subsidiary of Sosei Group Corporation, announces positive findings from its Phase 1b clinical... Read more
1d
Arkansas Democrat-Gazette
Drugmakers' pain-panel ties vex senatorWASHINGTON -- A high-ranking Senate Democrat is scrutinizing links between phar
Drugmakers' pain-panel ties vex senator
Arkansas Democrat-Gazette / Posted yesterday
WASHINGTON -- A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce the amount of prescribed painkillers. Sen. Ron Wyden says he has "a number of... Read more
11 related stories
1d
Business Wire
Erytech gibt seinen Finanzkalender für 2016 bekanntLYON, Frankreich--(BUSINESS WIRE)--ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext P
Erytech gibt seinen Finanzkalender für 2016 bekannt
Business Wire / Posted yesterday
LYON, Frankreich--(BUSINESS WIRE)--ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: FR0011471135 - ERYP),das französische Biopharma-Unternehmen, das innovative Behandlungen zur „Tumor-Aushungerung“ bei akuter Leukämie und anderen onkologischen... Read more
2907 related stories
1d
Boston Herald
Senator scrutinizes pharma links on government pain panelWASHINGTON — A high-ranking Senate Democrat is scrutinizing links between pharm
Senator scrutinizes pharma links on government pain panel
Boston Herald / Posted yesterday
WASHINGTON — A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing. Sen. Ron Wyden says he has a "number of concerns" about how... Read more
11 related stories
1d
Daily Herald
Senator scrutinizes pharma links on government pain panelWASHINGTON -- A high-ranking Senate Democrat is scrutinizing links between phar
Senator scrutinizes pharma links on government pain panel
Daily Herald / Posted yesterday
WASHINGTON -- A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing. Sen. Ron Wyden says he has a "number of concerns" about how... Read more
11 related stories
1d
Marietta Daily Journal
Senator scrutinizes pharma links on government pain panel - — A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescr...Sen. Ron Wyden says he has "a number of concerns" about how panelists were sele
Senator scrutinizes pharma links on government pain panel - — A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescr...
Marietta Daily Journal / Posted yesterday
Sen. Ron Wyden says he has "a number of concerns" about how panelists were selected and screened for an advisory panel on pain issues that includes government experts, outside academics and patient advocates. Wyden's inquiry follows a recent... Read more
11 related stories
1d
Orlando Sentinel
Senator scrutinizes pharma links on government pain panelA high-ranking Senate Democrat is scrutinizing links between pharmaceutical com
Senator scrutinizes pharma links on government pain panel
Orlando Sentinel / Posted yesterday
A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing. Sen. Ron Wyden says he has "a number of concerns" about how panelists... Read more
11 related stories
1d
ABC 7 Gulfshore News
Senator scrutinizes pharma links on government pain panelWASHINGTON (AP) - A high-ranking Senate Democrat is scrutinizing links between
Senator scrutinizes pharma links on government pain panel
ABC 7 Gulfshore News / Posted yesterday
WASHINGTON (AP) - A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing Sen. Ron Wyden says he has "a number of concerns" about... Read more
11 related stories
1d
KTEN North Texas & Southeastern Oklahoma
Senator scrutinizes pharma links on government pain panelWASHINGTON (AP) - A high-ranking Senate Democrat is scrutinizing links between
Senator scrutinizes pharma links on government pain panel
KTEN North Texas & Southeastern Oklahoma / Posted yesterday
WASHINGTON (AP) - A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing Sen. Ron Wyden says he has "a number of concerns" about... Read more
11 related stories
1d
Brandon Sun
Senator scrutinizes pharma links on government pain panelWASHINGTON - A high-ranking Senate Democrat is scrutinizing links between pharm
Senator scrutinizes pharma links on government pain panel
Brandon Sun / Posted yesterday
WASHINGTON - A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribing Sen. Ron Wyden says he has "a number of concerns" about how... Read more
11 related stories
1d
Yahoo News
Dow drops 300 as oil falls; gold surges 3% Pisani's market open led down by tech U.S. stocks fell sharply on Monday as
Dow drops 300 as oil falls; gold surges 3%
Yahoo News / Posted yesterday
Pisani's market open led down by tech U.S. stocks fell sharply on Monday as falling oil prices, U.S. rate increase worries and a weak overseas backdrop weighed on investors. Crude prices resumed their... Read more
4d
Investopedia
Forest Laboratories: An Activist Investment Analysis"If at first you don't succeed, try, try again" could have been billionaire inv
Forest Laboratories: An Activist Investment Analysis
Investopedia / Posted 4 days ago
"If at first you don't succeed, try, try again" could have been billionaire investor Carl Icahn's motto during his lengthy activist feud with Forest Laboratories Inc., the pharmaceutical and research giant eventually bought out by Actavis in 2014.... Read more
4d
National Post
Story | Business Wire News Releases | News | Financial PostThe Canadian pharmaceutical market is the eighth largest in the world, accounti
Story | Business Wire News Releases | News | Financial Post
National Post / Posted 4 days ago
The Canadian pharmaceutical market is the eighth largest in the world, accounting for about two percent of the world market by sales. Canada also has the fourth fastest growing pharmaceutical industry after China, the US and Spain and has shown a... Read more
5d
Morningstar
Pfizer's Pipeline Productivity Is ImprovingIn the quarter, growth from vaccine Prevnar 13 and recently launched drugs help
Pfizer's Pipeline Productivity Is Improving
Morningstar / Posted 5 days ago
In the quarter, growth from vaccine Prevnar 13 and recently launched drugs helped offset generic competition, leading to 5% year-over-year operational growth (excluding the Hospira acquisition). While the organic growth rate is likely to slow in 2016... Read more
5d
Business Wire
武田公佈2015會計年度三個季度(4-12月)的業績,再次確認全年的管理層指引4月至12月的結果再次肯定管理層全年指引 武田成長動力的貢獻 創新型新產品的成長抵消了喪失獨家權益的影響 2015會計年度全年預測顯示,營業利潤升級,其
武田公佈2015會計年度三個季度(4-12月)的業績,再次確認全年的管理層指引
Business Wire / Posted 5 days ago
4月至12月的結果再次肯定管理層全年指引 武田成長動力的貢獻 創新型新產品的成長抵消了喪失獨家權益的影響 2015會計年度全年預測顯示,營業利潤升級,其他未變 再次確認2015會計年度的管理層指引 武田總裁兼執行長Christophe... Read more
28 related stories
5d
Business Wire
武田公布2015财年三个季度(4-12月)的业绩,再次确认全年的管理层指引4月至12月的结果再次肯定管理层全年指引 武田成长动力的贡献 创新型新产品的增长抵消了丧失独家权益所带来的影响 效率增益得以持续 2015财年全年预测
武田公布2015财年三个季度(4-12月)的业绩,再次确认全年的管理层指引
Business Wire / Posted 5 days ago
4月至12月的结果再次肯定管理层全年指引 武田成长动力的贡献 创新型新产品的增长抵消了丧失独家权益所带来的影响 效率增益得以持续 2015财年全年预测显示,运营利润升级,其他未变 再次确认2015财年的管理层指引 武田总裁兼首席执行官Christophe... Read more
28 related stories
5d
San Antonio Express-News
Deckers Drops After Holiday Revenue, Guidance Fall ShortThe holidays are a key season for any consumer goods company, and Deckers Outdo
Deckers Drops After Holiday Revenue, Guidance Fall Short
San Antonio Express-News / Posted 5 days ago
The holidays are a key season for any consumer goods company, and Deckers Outdoor depends on a successful gift-giving season to support its business. Coming into Thursday's fiscal third-quarter financial report, Deckers investors wanted to see that... Read more
5d
Orange County Business Journal
Sanuk Revenue Falls 17%Sanuk USA LLC’s revenue for the third quarter of its fiscal year 2016 decreased
Sanuk Revenue Falls 17%
Orange County Business Journal / Posted 5 days ago
Sanuk USA LLC’s revenue for the third quarter of its fiscal year 2016 decreased 17% to $17 million compared to $20.5 million in the same period last year, according to parent company Deckers Outdoor Corp. in Goleta. The sandal maker is closing its... Read more
5d
Market Watch
UGG maker Deckers lowers guidance, plans cost cutsThe company also lowered its guidance for the current quarter. Shares fell 7.8
UGG maker Deckers lowers guidance, plans cost cuts
Market Watch / Posted 5 days ago
The company also lowered its guidance for the current quarter. Shares fell 7.8%, to $45, in after-hours trading. Deckers, with 145 stores as of Sept. 30, said 20 locations are candidates to be closed. The company will close the Sanuk office in... Read more
5d
Yahoo News
Martin Shkreli could not stop laughing during his testimony to Congress Infamous former Turing CEO Martin Shkreli and Howard Schiller, the interim ch
Martin Shkreli could not stop laughing during his testimony to Congress
Yahoo News / Posted 5 days ago
Infamous former Turing CEO Martin Shkreli and Howard Schiller, the interim chief executive of the pharmaceutical company Valeant, just faced Congress. Legislators on Thursday... Read more
354 related stories
6d
Business Insider
Martin Shkreli could not stop laughing during his testimony to CongressHoward Schiller, the interim chief executive of pharmaceutical company Valeant,
Martin Shkreli could not stop laughing during his testimony to Congress
Business Insider / Posted 6 days ago
Howard Schiller, the interim chief executive of pharmaceutical company Valeant, and infamous former Turing CEO Martin Shkreli just faced Congress. Legislators wanted them to answer for dramatic drug price increases that impact the lives of... Read more
6d
National Post
Story | Business Wire News Releases | News | Financial PostLe redressement se poursuit grâce aux moteurs de croissance de Takeda : la gast
Story | Business Wire News Releases | News | Financial Post
National Post / Posted 6 days ago
Le redressement se poursuit grâce aux moteurs de croissance de Takeda : la gastroentérologie, l’oncologie et les marchés émergents OSAKA, Japon--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO : 4502) : Les résultats de la période... Read more
467 related stories
6d
MedCity News
Mass General president joins American Well boardTelemedicine service provider American Well has added another luminary to its b
Mass General president joins American Well board
MedCity News / Posted 6 days ago
Telemedicine service provider American Well has added another luminary to its board: Dr. Peter Slavin, president of Massachusetts General Hospital. Slavin joins the likes of former Massachusetts Gov. Deval Patrick and Brendan O’Grady, CEO of Teva... Read more
6d
Business Wire
Erytech meldet Präsentationen auf bevorstehenden InvestorenkonferenzenLYON, Frankreich--(BUSINESS WIRE)--ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext P
Erytech meldet Präsentationen auf bevorstehenden Investorenkonferenzen
Business Wire / Posted 6 days ago
LYON, Frankreich--(BUSINESS WIRE)--ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: FR0011471135 - ERYP),das französische Biopharma-Unternehmen, das innovative Behandlungen zur Tumor-Aushungerung bei akuter Leukämie und anderen onkologischen... Read more
2907 related stories
6d
The Daily Jeffersonian
Federal pain panel rife with links to industry companiesMatthew Perrone AP Health Writer Published: February 3, 2016 11:00 AM WASHINGT
Federal pain panel rife with links to industry companies
The Daily Jeffersonian / Posted 6 days ago
Matthew Perrone AP Health Writer Published: February 3, 2016 11:00 AM WASHINGTON (AP) -- Nearly a third of the members on a government panel that made headlines by calling an effort to curb... Read more
7d
National Post
Story | Business Wire News Releases | News | Financial PostContinues Turnaround with Takeda's Growth Drivers: Gastroenterology, Oncology a
Story | Business Wire News Releases | News | Financial Post
National Post / Posted 7 days ago
Continues Turnaround with Takeda's Growth Drivers: Gastroenterology, Oncology and Emerging Markets OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502): Results of April to December period reaffirms full-year management... Read more
7d
Business Wire
Takeda Reports Results for Three Quarters (April-December) of FY2015, Reaffirms Management Guidance for the Full YearResults of April to December period reaffirms full-year management guidance Co
Takeda Reports Results for Three Quarters (April-December) of FY2015, Reaffirms Management Guidance for the Full Year
Business Wire / Posted 7 days ago
Results of April to December period reaffirms full-year management guidance Contribution of Takeda's growth drivers Growth of innovative new products to offset loss of exclusivity impact Efficiency gains continue For FY2015 full year reported... Read more
7d
TheStreet.com
4 "momentum triggers" that could give this biotech stock 64% growthThe development of orphan drugs is a booming niche and Teva has been muscling i
4 "momentum triggers" that could give this biotech stock 64% growth
TheStreet.com / Posted 7 days ago
The development of orphan drugs is a booming niche and Teva has been muscling in. The company is developing cancer drugs in orphan and other cancer indications for the treatment of patients who are failing to respond to existing conventional... Read more
7d
TheStreet.com
4 "momentum triggers" that could give this biotech stock 64% growthThe race is on for new sources of growth in the pharmaceutical industry, as blo
4 "momentum triggers" that could give this biotech stock 64% growth
TheStreet.com / Posted 7 days ago
The race is on for new sources of growth in the pharmaceutical industry, as blockbuster drugs lose patent protection and competitors join forces to cut costs. It spells outsized growth for the right biotech company, especially one that's about to... Read more
7d
San Antonio Express-News
Why Opko Health's Shares Fell 20% in JanuaryWhat: Despite outlining plans for the future at J.P. Morgan's annual healthcare
Why Opko Health's Shares Fell 20% in January
San Antonio Express-News / Posted 7 days ago
What: Despite outlining plans for the future at J.P. Morgan's annual healthcare conference early last month, shares in Opko Health, slid 20% in January, according to S&P Capital IQ. So what: On January 12, Opko Health offered up insight into its... Read more
7d
Orange County Register
So long, Sanuk: Surf-inspired shoe maker to relocate HQ to Goleta from IrvineSanuk, an Irvine-based footwear maker, will be moving to Goleta in Santa Barbar
So long, Sanuk: Surf-inspired shoe maker to relocate HQ to Goleta from Irvine
Orange County Register / Posted 7 days ago
Sanuk, an Irvine-based footwear maker, will be moving to Goleta in Santa Barbara County where its parent company, Deckers Outdoor, is headquartered, a company spokesperson said Tuesday. As part of the consolidation, some employees will be moving... Read more
8d
San Antonio Express-News
3 Stocks Wall Street HatesSource: Flickr user Dennis Skley. Companies fall out of favor with investors f
3 Stocks Wall Street Hates
San Antonio Express-News / Posted 8 days ago
Source: Flickr user Dennis Skley. Companies fall out of favor with investors for all sorts of reasons, but Wall Street's pessimism isn't always warranted. To see if that's the case for these three unloved companies, we asked a few of our top Motley... Read more
8d
National Post
Story | Business Wire News Releases | News | Financial PostAgreement Further Supports Teva’s Novel Biologics Development Program JERUSALE
Story | Business Wire News Releases | News | Financial Post
National Post / Posted 8 days ago
Agreement Further Supports Teva’s Novel Biologics Development Program JERUSALEM & VANCOUVER, British Columbia--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and AbCellera have entered into a collaborative research... Read more
8d
San Antonio Express-News
Can Deckers Outdoor Start 2016 on the Right Foot?Image: Deckers Outdoor. Footwear and apparel specialist Deckers Outdoor finds
Can Deckers Outdoor Start 2016 on the Right Foot?
San Antonio Express-News / Posted 8 days ago
Image: Deckers Outdoor. Footwear and apparel specialist Deckers Outdoor finds itself in a tough market environment right now. The rise of athletic apparel for all-purpose use has put companies like Under Armour in position to take maximum... Read more
2 related stories
8d
Orange County Business Journal
Sanuk to Exit Irvine HQDeckers Outdoor Corp. said it will move Irvine-based sandal maker Sanuk USA LLC
Sanuk to Exit Irvine HQ
Orange County Business Journal / Posted 8 days ago
Deckers Outdoor Corp. said it will move Irvine-based sandal maker Sanuk USA LLC to its headquarters in Goleta to help “streamline brand operations and reduce infrastructure costs.” Sanuk has 45 employees and leases a 48,000-square-foot building at... Read more
8d
Channel NewsAsia
US appeals court ruling may clear barrier to generic OxyContinREUTERS: A federal appeals court ruled Monday that four patents related to Purd
US appeals court ruling may clear barrier to generic OxyContin
Channel NewsAsia / Posted 8 days ago
REUTERS: A federal appeals court ruled Monday that four patents related to Purdue Pharma's painkiller OxyContin are invalid, potentially bringing Teva Pharmaceutical Industries Ltd and others a step closer to introducing generic versions of the... Read more
9d
Liverpool Echo
Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing siteThe Runcorn operation of pharmaceutical company Teva has announced plans to mak
Pharmaceutical firm Teva to axe jobs at its Runcorn manufacturing site
Liverpool Echo / Posted 9 days ago
The Runcorn operation of pharmaceutical company Teva has announced plans to make around 60 redundancies as part of a shake-up to improve its offer. Teva said it would try and keep job losses to a minimum by identifying redeployment opportunities... Read more
9d
Market Watch
Will Uggs get a boost from Carol Burnett’s SAG Awards red carpet appearance?One brand that is not expected on a red carpet made an appearance Saturday nigh
Will Uggs get a boost from Carol Burnett’s SAG Awards red carpet appearance?
Market Watch / Posted 9 days ago
One brand that is not expected on a red carpet made an appearance Saturday night, when Carol Burnett donned a pair of Ugg slippers for the Screen Actors Guild Awards. On hand to receive the SAG Life Achievement Award, the comedy icon was snapped in... Read more
10d
Denton Record-Chronicle
Federal pill panel rife with links to pharma companiesWASHINGTON — A federal panel that has recently criticized efforts to cut back o
Federal pill panel rife with links to pharma companies
Denton Record-Chronicle / Posted 10 days ago
WASHINGTON — A federal panel that has recently criticized efforts to cut back on painkiller prescriptions is studded with members who have financial ties to drug companies. Nearly a third of members on the Interagency Pain Research Coordinating... Read more
11d
TheStreet.com
Antitrust Watchdog: Usual Merger Fix Won't Help Teva's Allergan Deal The American Antitrust Institute has taken a stand against Israel-based Teva
Antitrust Watchdog: Usual Merger Fix Won't Help Teva's Allergan Deal
TheStreet.com / Posted 11 days ago
The American Antitrust Institute has taken a stand against Israel-based Teva Pharmaceuticals Inc. (TEVA)'s $40.5 billion deal to acquire the generics operation of Allergan plc... Read more
12d
Business Wire
Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine hydrochloride) InjectionJERUSALEM & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Teva Pharmaceutical Industri
Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine hydrochloride) Injection
Business Wire / Posted 12 days ago
JERUSALEM & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced today the commercial availability of BENDEKA™, (bendamustine hydrochloride)... Read more
13d
Investopedia
Allergan: An Activist Investment Analysis (AGN,VRX)There is perhaps no better company than Allergan plc (NYSE: AGN) to illustrate
Allergan: An Activist Investment Analysis (AGN,VRX)
Investopedia / Posted 13 days ago
There is perhaps no better company than Allergan plc (NYSE: AGN) to illustrate the massive amount of mergers and acquisition activity in the pharmaceutical space in 2014 and 2015, as well as the tribulations of some players in the sector. Allergan... Read more
6 related stories
13d
Bennington Banner
Federal pain panel rife with links to pharma companiesWASHINGTON >> A federal panel that has recently criticized efforts to cut
Federal pain panel rife with links to pharma companies
Bennington Banner / Posted 13 days ago
WASHINGTON >> A federal panel that has recently criticized efforts to cut back on painkiller prescriptions is studded with members who have financial ties to drug companies. Nearly a third of members on the Interagency Pain Research... Read more
12 related stories
13d
Business Wire
Fitch Affirms Cardinal Health at 'BBB+' Outlook StableCHICAGO--(BUSINESS WIRE)--Fitch Ratings has affirmed the ratings for Cardinal H
Fitch Affirms Cardinal Health at 'BBB+' Outlook Stable
Business Wire / Posted 13 days ago
CHICAGO--(BUSINESS WIRE)--Fitch Ratings has affirmed the ratings for Cardinal Health, Inc. (NYSE: CAH), including the Long-term Issuer Default Rating (IDR) at 'BBB+' and Short-term IDR at 'F2'. The Rating Outlook is Stable. A full list of rating... Read more
5 related stories
13d
The San Angelo Standard-Times
Federal pain panel rife with links to pharma companiesWASHINGTON (AP) — A federal panel that has recently criticized efforts to cut b
Federal pain panel rife with links to pharma companies
The San Angelo Standard-Times / Posted 13 days ago
WASHINGTON (AP) — A federal panel that has recently criticized efforts to cut back on painkiller prescriptions is studded with members who have financial ties to drug companies. Nearly a third of members on the Interagency Pain Research Coordinating... Read more
12 related stories
13d
The Register NorthJersey.com
Federal pain panel rife with links to pharma companiesWASHINGTON - A federal panel that has recently criticized efforts to cut back o
Federal pain panel rife with links to pharma companies
The Register NorthJersey.com / Posted 13 days ago
WASHINGTON - A federal panel that has recently criticized efforts to cut back on painkiller prescriptions is studded with members who have financial ties to drug companies. Nearly a third of members on the Interagency Pain Research Coordinating... Read more
12 related stories
13d
The Monroe Evening News
Federal pain panel rife with links to pharma companiesWASHINGTON (AP) — A federal panel that has recently criticized efforts to cut b
Federal pain panel rife with links to pharma companies
The Monroe Evening News / Posted 13 days ago
WASHINGTON (AP) — A federal panel that has recently criticized efforts to cut back on painkiller prescriptions is studded with members who have financial ties to drug companies. Nearly a third of members on the Interagency Pain Research Coordinating... Read more
12 related stories
13d
Brandon Sun
Federal pain panel rife with links to pharma companiesWASHINGTON - A federal panel that has recently criticized efforts to cut back o
Federal pain panel rife with links to pharma companies
Brandon Sun / Posted 13 days ago
WASHINGTON - A federal panel that has recently criticized efforts to cut back on painkiller prescriptions is studded with members who have financial ties to drug companies. Nearly a third of members on the Interagency Pain Research Coordinating... Read more
12 related stories
13d
Marietta Daily Journal
Federal pain panel rife with links to pharma companies - — Nearly a third of the members on a government panel that made headlines by calling an effort to curb overprescribing of OxyContin and other painkillers horrible have dru...The Interagency Pain Research Coordinating Committee is a government advisory p
Federal pain panel rife with links to pharma companies - — Nearly a third of the members on a government panel that made headlines by calling an effort to curb overprescribing of OxyContin and other painkillers horrible have dru...
Marietta Daily Journal / Posted 13 days ago
The Interagency Pain Research Coordinating Committee is a government advisory panel of federal scientists, outside academics and patient representatives. Of the 18 committee members at a recent meeting to discuss government handling of pain issues,... Read more
12 related stories
13d
TribLIVE
Strong money ties between drug companies, federal pain panel raise questions Neighborhoods WASHINGTON — Nearly a third of the members on a government p
Strong money ties between drug companies, federal pain panel raise questions
TribLIVE / Posted 13 days ago
Neighborhoods WASHINGTON — Nearly a third of the members on a government panel that made... Read more
12 related stories
More

People in this news